News

SABCS 2025: Sacituzumab govitecan-hziy led to similar progression-free survival as standard of care for certain endocrine therapy-refractory advanced breast cancers

SABCS 2025: Adding tucatinib to first-line maintenance therapy delayed disease progression in HER2-positive metastatic breast cancer in HER2CLIMB-05 trial

SABCS 2025: Breast MRI may be safely omitted from diagnostic workup in certain patients with early-stage, HR-negative breast cancer

SABCS 2025: Sentinel lymph node biopsy may be safely omitted in some patients with early-stage breast cancer

SABCS 2025: Preoperative radiation may improve antitumour immune response in most common form of breast cancer

Targeting collagen signaling boosts drug delivery in pancreatic cancer

How gut bacteria could protect young adults from cancer

Routine scans could detect early prostate radiotherapy changes

Researchers develop next-generation CAR T cells that show stronger, safer response in animal models

New paper-based technology could transform cancer drug testing

New study charts paths to end cervical cancer

Researchers find new hope for toughest myeloma through off-the-shelf immunotherapy